ChinaBio News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

>> Preview...
In the News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

CRO BioDuro Signs Collaboration with AstraZeneca in Beijing

publication date: Mar 17, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

BioDuro and AstraZeneca held a signing ceremony in Beijing today to formalize their new collaboration. BioDuro is a CRO based in the US, though its operations are entirely in Beijing. The company offers end-to-end medicinal chemistry services, either from its team of 580 or through affiliations with partners. AstraZeneca produced revenues of more than $31 billion last year from its portfolio of pharmaceuticals. More details...

Stock Symbol: (NYSE: AZN)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

SEED Finalists Coaching Day
March 2, 2010
Shanghai, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
 
Partner Events

March 8–10, 2010
Barcelona, Spain

World CRO Summit 2010
March 11-12, 2010
Shanghai, China

BIO-Europe 2010
Munich, Germany
November 15–17, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners